Rheumatology International

, Volume 32, Issue 1, pp 1–3

Successful use of Etanercept for the treatment of Reiter’s syndrome: a case report and review of the literature

Review Article

DOI: 10.1007/s00296-011-2000-1

Cite this article as:
Edrees, A. Rheumatol Int (2012) 32: 1. doi:10.1007/s00296-011-2000-1


The treatment of severe and refractory cases of reactive arthritis is not well defined. There is a limited data about the use of tumor necrosis factor-α (TNF-α) blockers in reactive arthritis. Herein is a description of a patient with severe case of Chlamydia trachomatis-related reactive arthritis that was refractory to nonsteroidal anti-inflammatory drugs, sulfasalazine, prednisone, and methotrexate and was successfully treated with etanercept.


Reactive arthritisTumor necrosis factor-α (TNF-α) blockersEtanercept

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  1. 1.University of Missouri-Kansas CityKansas CityUSA